Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 205,324 | 0 | 0 | N/A | 0 |
| Marketable Securities | 8,025 | 0 | 0 | N/A | 0 |
| Receivables | 609 | 0 | 0 | N/A | 0 |
| Other current assets | 127 | 0 | 0 | 0 | 0 |
| TOTAL | $215,485 | $0 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 385 | N/A | N/A | N/A | N/A |
| Investments And Advances | 11,316 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 128 | 0 | 0 | 0 | 0 |
| TOTAL | $11,829 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $227,314 | $0 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,454 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 1,727 | 0 | 0 | N/A | 0 |
| Other current liabilities | 127 | 0 | 0 | N/A | 0 |
| TOTAL | $5,308 | $0 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $198 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,506 | $0 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,313 | N/A | N/A | N/A | N/A |
| Common Shares | 3 | 0 | 0 | N/A | 0 |
| Retained earnings | -46,444 | 0 | 0 | N/A | 0 |
| Other shareholders' equity | -26 | 0 | 0 | 0 | 0 |
| TOTAL | $221,808 | $0 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $227,314 | $0 | $0 | $0 | $0 |